Skip to main content
. 2020 Apr 14;33(3):285–292. doi: 10.20524/aog.2020.0481

Table 1.

Baseline characteristics of 12 kidney transplant (KT) recipients with chronic hepatitis C (CHC) who received antiviral therapy with direct acting antivirals (DAAs)

graphic file with name AnnGastroenterol-33-285-g001.jpg